Trending Topic

23 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Luke G Qin, Michael T Pierce, Rachel C Robbins

The uvea is a vascular stratum that includes the iris, ciliary body and choroid. Uveitis is defined as inflammation of a part of the uvea or its entirety, but it is also used to describe inflammatory processes of any part of the eye, such as the vitreous or peripheral retina. The clinical taxonomy of uveitis […]

David Hunter, AAPOS 2021: Luminopia One Amblyopia Vision Improvement Study

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Apr 19th 2021

It was a pleasure to speak with Dr David Hunter (Harvard Medical School, Boston, MA, USA) about the Luminopia One Amblyopia Vision Improvement Study, which were presented at AAPOS 2021.

Questions

  1. What are the aims and design of the Luminopia One Amblyopia Vision Improvement Study?
  2. What are the primary and secondary outcome measures of the study?
  3. What have been the findings of the study to date?

Speaker Disclosure: David Hunter discloses the following: Advisor and equity holder, Luminopia, Inc. Board member and equity holder, Rebion Inc.

Support: Interview and filming supported by Touch Medical Media Ltd.

Filmed in coverage of AAPOS 2021.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup